Cite This Page
Bibliographic details for Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues
- Page name: Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 29 January 2024 07:09 UTC
- Date retrieved: 16 May 2024 17:00 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788
- Page Version ID: 624788
Citation styles for Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues
APA style
Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues. (2024, January 29). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 17:00, May 16, 2024 from https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788.
MLA style
"Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 29 Jan 2024, 07:09 UTC. 16 May 2024, 17:00 <https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 29 January 2024, 07:09 UTC, <https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788> [accessed 16 May 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788 (accessed May 16, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 29, 07:09 UTC [cited 2024 May 16]. Available from: https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788.
Bluebook style
Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues, https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788 (last visited May 16, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788", note = "[Online; accessed 16-May-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Computational Study regarding Gantenerumab along with Crenezumab Reputation associated with A Fibrils in Alzheimers Disease Mental faculties Tissues --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Computational_Study_regarding_Gantenerumab_along_with_Crenezumab_Reputation_associated_with_A_Fibrils_in_Alzheimers_Disease_Mental_faculties_Tissues&oldid=624788}", note = "[Online; accessed 16-May-2024]" }